Literature DB >> 21132680

Exploring and comparing the experience and coping behaviour of men and women with colorectal cancer after chemotherapy treatment: a qualitative longitudinal study.

Eilis McCaughan1, Gillian Prue, Kader Parahoo, Sonja McIlfatrick, Hugh McKenna.   

Abstract

OBJECTIVES: Men have higher incidence and mortality rates for nearly all cancers. They are less likely than women to utilise cancer information services and other social support services. The aim of this study was to explore and compare the experience and coping behaviour of men and women after treatment for colorectal cancer (CRC).
METHODS: A longitudinal qualitative study was conducted involving 38 individuals (24 men and 14 women) with CRC. Data were generated using semi-structured interviews at four time points over an 18-month period, post-diagnosis. Interviews focused on participant's experience of CRC and on how gender affected their coping. This paper reports the findings of interviews 3 and 4 which examined the participant's experience after chemotherapy.
RESULTS: Three themes emerged from the interviews ('new normal', living with uncertainty and support needs). Many men and women reacted similarly; however, there was some variation evident between and within sexes. The main difference was with regard to the long-term physical side effects of the illness. Many women admitted to still experiencing side effects, whereas many men indicated that they had no problems. These men engaged in practices that aligned with their gender identity and view of masculinity. It must be noted that some men and women were still experiencing an impact.
CONCLUSIONS: Recovery from the physical and psychological effects of CRC does not occur simultaneously. Healthcare professionals should be aware that not all men (or women) conform to the social stereotypes of masculinity (or femininity).
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21132680     DOI: 10.1002/pon.1871

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  7 in total

1.  Working Toward Normalcy Post-Treatment: A Qualitative Study of Older Adult Breast and Prostate Cancer Survivors.

Authors:  Rachel Walker; Sarah L Szanton; Jennifer Wenzel
Journal:  Oncol Nurs Forum       Date:  2015-11       Impact factor: 2.172

2.  Self-Reorientation Following Colorectal Cancer Treatment - A Grounded Theory Study.

Authors:  Ann-Caroline B Johansson; Malin Axelsson; Ina Berndtsson; Eva Brink
Journal:  Open Nurs J       Date:  2015-06-26

3.  Chronic disease management perspectives of colorectal cancer survivors using the Veterans Affairs healthcare system: a qualitative analysis.

Authors:  Leah L Zullig; Karen M Goldstein; Hayden B Bosworth; Sara M Andrews; Susanne Danus; George L Jackson; Dawn Provenzale; Morris Weinberger; Michael J Kelley; Corrine I Voils
Journal:  BMC Health Serv Res       Date:  2018-03-09       Impact factor: 2.655

4.  Prevalence vs impact: a mixed methods study of survivorship issues in colorectal cancer.

Authors:  Amanda Drury; Sheila Payne; Anne-Marie Brady
Journal:  Qual Life Res       Date:  2021-08-21       Impact factor: 4.147

5.  Gender Differences in Coping, Depression, and Anxiety in Patients with Non-Metastatic Lung Cancer.

Authors:  Elisei Moise Hasan; Crenguta Livia Calma; Anca Tudor; Corina Vernic; Emanuel Palade; Emanuela Tudorache; Cristian Oancea; Ion Papava
Journal:  Cancer Manag Res       Date:  2022-06-20       Impact factor: 3.602

Review 6.  The impact of testicular cancer and its treatment on masculinity: A systematic review.

Authors:  Victoria Dax; Maria Ftanou; Ben Tran; Jeremy Lewin; Rebecca Wallace; Zac Seidler; Joshua F Wiley
Journal:  Psychooncology       Date:  2022-07-21       Impact factor: 3.955

7.  Developing longitudinal qualitative designs: lessons learned and recommendations for health services research.

Authors:  Lynn Calman; Lisa Brunton; Alex Molassiotis
Journal:  BMC Med Res Methodol       Date:  2013-02-06       Impact factor: 4.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.